Related references
Note: Only part of the references are listed.Effect of bromhexine in hospitalized patients with COVID-19
Ramin Tolouian et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2023)
Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2, the pathophysiology of COVID-19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
Periklis Katopodis et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)
Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2
Eric A. Klein et al.
JOURNAL OF UROLOGY (2021)
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection
Lukas Paulsson-Habegger et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation
Wakana Takahashi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
Xiyuan Bai et al.
MEDICAL HYPOTHESES (2021)
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
Chengliang Yang et al.
LANCET RESPIRATORY MEDICINE (2021)
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
Tiffany Tang et al.
ACS INFECTIOUS DISEASES (2021)
COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Periklis Katopodis et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer.
Vaibhav G. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic
Rolf Gedeborg et al.
PLOS ONE (2021)
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
Fei Li et al.
NATURE COMMUNICATIONS (2021)
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann et al.
EBIOMEDICINE (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID-19
Junsaku Kitagawa et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
Andrew L. Schmidt et al.
JAMA NETWORK OPEN (2021)
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Lukas Wettstein et al.
NATURE COMMUNICATIONS (2021)
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
Thomas P. Peacock et al.
NATURE MICROBIOLOGY (2021)
Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells
Dorothea Bestle et al.
JOURNAL OF VIROLOGY (2021)
Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients
Estibaliz Jimenez-Alcaide et al.
PROSTATE (2021)
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
Kun Li et al.
MBIO (2021)
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry
Yanwen Chen et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann et al.
CELL REPORTS (2021)
How SARS-CoV-2 makes the cut
Markus Hoffmann et al.
NATURE MICROBIOLOGY (2021)
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)
Jihye Lee et al.
MICROBIOLOGY SPECTRUM (2021)
Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial
Sergey Zhuravel et al.
ECLINICALMEDICINE (2021)
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
Xin Hu et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial
Jesper D. Gunst et al.
ECLINICALMEDICINE (2021)
Structure-based phylogeny identifies avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice
Young Joo Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat
Tim Hempel et al.
CHEMICAL SCIENCE (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
Oliver J. McElvaney et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
Soeren Lukassen et al.
EMBO JOURNAL (2020)
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
Sukbin Jang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses
Marco R. Straus et al.
VIROLOGY (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Temporal dynamics in viral shedding and transmissibility of COVID-19
Xi He et al.
NATURE MEDICINE (2020)
Characterization of the Inflammatory Response to Severe COVID-19 Illness
Oliver J. McElvaney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Pathogenesis of COVID-19-induced ARDS: implications for an ageing population
Manuel A. Torres Acosta et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis
Chun-Jung Ko et al.
ONCOGENE (2020)
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Ting Li et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates
Guy Shapira et al.
FASEB JOURNAL (2020)
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Mizuki Yamamoto et al.
VIRUSES-BASEL (2020)
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Khalil Ansarin et al.
BIOIMPACTS (2020)
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
Aristides Tsatsakis et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
Chengliang Yang et al.
FRONTIERS IN PHARMACOLOGY (2020)
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H. Shrimp et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
Kent Doi et al.
CRITICAL CARE (2020)
The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy A Pilot Clinical Trial
Michael A. Campos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis
Ruth L. O. Lambertz et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression
Nisha R. Pawar et al.
CANCER RESEARCH (2019)
Anti-varicella-zoster virus activity of cephalotaxine esters in vitro
Jung-Eun Kim et al.
JOURNAL OF MICROBIOLOGY (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Entry of Human Coronavirus NL63 into the Cell
Aleksandra Milewska et al.
JOURNAL OF VIROLOGY (2018)
Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2018)
Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
Jean Kaoru Millet et al.
VIROLOGY (2018)
Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
Kazuya Shirato et al.
VIROLOGY (2018)
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
Hannah Kleine-Weber et al.
SCIENTIFIC REPORTS (2018)
Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2017)
Airway proteases: an emerging drug target for influenza and other respiratory virus infections
Manon Laporte et al.
CURRENT OPINION IN VIROLOGY (2017)
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Li Wen Shen et al.
BIOCHIMIE (2017)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
Greg L. Shaw et al.
EUROPEAN UROLOGY (2016)
The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases
Nora Kuehn et al.
JOURNAL OF VIROLOGY (2016)
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
Jung-Eun Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus
Kouji Sakai et al.
SCIENTIFIC REPORTS (2016)
Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments
Sabina Janciauskiene et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
Jianzhong Cao et al.
ANTIVIRAL RESEARCH (2015)
Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis
Chun-Jung Ko et al.
CANCER RESEARCH (2015)
Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics
Wolfgang Garten et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2015)
A Mutant H3N2 Influenza Virus Uses an Alternative Activation Mechanism in TMPRSS2 Knockout Mice by Loss of an Oligosaccharide in the Hemagglutinin Stalk Region
Kouji Sakai et al.
JOURNAL OF VIROLOGY (2015)
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
Mutsuo Yamaya et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema
Alessandro N. Franciosi et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
The evolution of the scavenger receptor cysteine-rich domain of the class A scavenger receptors
Nicholas V. L. Yap et al.
FRONTIERS IN IMMUNOLOGY (2015)
Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity
Stefanie Gierer et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells
Pawel Zmora et al.
PLOS ONE (2015)
Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2
Brian S. Hamilton et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
TMPRSS2 Is a Host Factor That Is Essential for Pneumotropism and Pathogenicity of H7N9 Influenza A Virus in Mice
Carolin Tarnow et al.
JOURNAL OF VIROLOGY (2014)
The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses
Kouji Sakai et al.
JOURNAL OF VIROLOGY (2014)
Cleavage Specificity Analysis of Six Type II Transmembrane Serine Proteases (TTSPs) Using PICS with Proteome-Derived Peptide Libraries
Olivier Barre et al.
PLOS ONE (2014)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Jared M. Lucas et al.
CANCER DISCOVERY (2014)
Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Christina C. Chang et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression
Parveen Kaur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Identification of the first synthetic inhibitors of the type II transmembrane serine protease IMPRSS2 suitable for inhibition of influenza virus activation
Daniela Meyer et al.
BIOCHEMICAL JOURNAL (2013)
Safety and Pharmacokinetics of 120 mg/kg versus 60 mg/kg Weekly Intravenous Infusions of Alpha-1 Proteinase Inhibitor in Alpha-1 Antitrypsin Deficiency: A Multicenter, Randomized, Double-Blind, Crossover Study (SPARK)
Michael A. Campos et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013)
Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation
Kuniyo Inouye et al.
JOURNAL OF BIOCHEMISTRY (2013)
Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses
Joanna Baron et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2013)
TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2013)
TMPRSS2 Is an Activating Protease for Respiratory Parainfluenza Viruses
Masako Abe et al.
JOURNAL OF VIROLOGY (2013)
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Stefanie Gierer et al.
JOURNAL OF VIROLOGY (2013)
Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase
Danny Jonigk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
Bastian Hatesuer et al.
PLOS PATHOGENS (2013)
Influenza HA Subtypes Demonstrate Divergent Phenotypes for Cleavage Activation and pH of Fusion: Implications for Host Range and Adaptation
Summer E. Galloway et al.
PLOS PATHOGENS (2013)
Androgen deprivation therapy: past, present and future
F. Schroeder et al.
BJU INTERNATIONAL (2012)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Tracy L. Keller et al.
NATURE CHEMICAL BIOLOGY (2012)
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
Stephanie Bertram et al.
PLOS ONE (2012)
Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections
Eva Boettcher-Friebertshaeuser et al.
VACCINE (2012)
New 3-amidinophenylalanine-derived inhibitors of matriptase
Maya Hammami et al.
MEDCHEMCOMM (2012)
Aprotinin and similar protease inhibitors as drugs against influenza
O. P. Zhirnov et al.
ANTIVIRAL RESEARCH (2011)
Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT
Frank Sielaff et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
Sang Jin Han et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
Ana Shulla et al.
JOURNAL OF VIROLOGY (2011)
Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Progress in the development of human parainfluenza virus vaccines
Alexander C. Schmidt et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2011)
TMPRSS2, a Serine Protease Expressed in the Prostate on the Apical Surface of Luminal Epithelial Cells and Released into Semen in Prostasomes, Is Misregulated in Prostate Cancer Cells
Ya-Wen Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2
Mihiret Tekeste Sisay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2010)
Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors
Eva Boettcher-Friebertshaeuser et al.
JOURNAL OF VIROLOGY (2010)
Androgen receptor and androgen-dependent gene expression in lung
Laura Mikkonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Prostate-Specific Antigen (PSA) Is Activated by KLK2 in Prostate Cancer Ex Vivo Models and in Prostate-Targeted PSA/KLK2 Double Transgenic Mice
Simon A. Williams et al.
PROSTATE (2010)
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
Stephanie Bertram et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia
Laura Silvestri et al.
BLOOD (2009)
Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency
P. Brand et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Type II Transmembrane Serine Proteases
Thomas H. Bugge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protease-Mediated Entry via the Endosome of Human Coronavirus 229E
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2009)
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Chawaree Chaipan et al.
JOURNAL OF VIROLOGY (2009)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Superior Outcome of Nafamostat Mesilate as an Anticoagulant in Patients Undergoing Maintenance Hemodialysis with Intracerebral Hemorrhage
Jae Won Yang et al.
RENAL FAILURE (2009)
MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition
Eva Boettcher et al.
VACCINE (2009)
TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness
Michel Guipponi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
Roman Szabo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Proteases: Multifunctional Enzymes in Life and Disease
Carlos Lopez-Otin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines
K. Kosai et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2008)
The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma
J. M. Lucas et al.
JOURNAL OF PATHOLOGY (2008)
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2
Yuta Shirogane et al.
JOURNAL OF VIROLOGY (2008)
Preservation of in vitro function of platelets stored in the presence of a synthetic dual inhibitor of factor Xa and thrombin
P. Hellstern et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium
Eva Böttcher et al.
JOURNAL OF VIROLOGY (2006)
Secondary amides of sulfonylated 3-amidinophenylalanine.: New potent and selective inhibitors of matriptase
Torsten Steinmetzer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells
IC Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Phenotypic analysis of mice lacking the Tmprss2-encoded protease
TS Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity
K Kono et al.
AMERICAN JOURNAL OF SURGERY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells
S Wilson et al.
BIOCHEMICAL JOURNAL (2005)
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
H Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents
A Schweinitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Serine protease mechanism and specificity
L Hedstrom
CHEMICAL REVIEWS (2002)
Protease-activated receptors: A means of converting extracellular proteolysis into intracellular signals
EJ Mackie et al.
IUBMB LIFE (2002)
Regulation of the epithelial sodium channel by serine proteases in human airways
SH Donaldson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients:: Detection of mutated TMPRSS2 form in a case of aggressive disease
MH Vaarala et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Cloning and characterization of the cDNA and gene for human epitheliasin
E Jacquinet et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
The kinetic and structural characterization of the reaction of nafamostat with bovine pancreatic trypsin
MK Ramjee et al.
THROMBOSIS RESEARCH (2000)
Share Paper
